1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow Hormone Receptor Positive: new trials by email Literature Review of Hormone Receptor Positive trials Research Report on Hormone Receptor Positive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) Anastrozole, Exemestane, Laboratory Biomarker Analysis - Breast Adenocarcinoma, Hormone Receptor Positive | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 10273 | 2006-04-07 | 2026-10-01 |
Breast Neoplasms (1)
Breast Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Anastrozole (1) · Letrozole (1) · Radiation (1) · Radiotherapy (1) · Tamoxifen (1) · exemestane (1)
National Cancer Institute (NCI) (1)
Australia (1) · Canada (1) · Ireland (1) · New Zealand (1) · Peru (1) · Puerto Rico (1) · United Kingdom (1) · United States (1)
Joseph A Sparano (1)
PMID 26412349, PMID 29860917, PMID 31157962, PMID 31409130, PMID 31566680, PMID 32271671, PMID 33626896, PMID 34090143, PMID 34137783, PMID 35175284, PMID 37043210
U10CA021115 (1), U10CA180820 (1)